Tag: CRDMO
GENERAL Aurobindo Pharma Acquires A1 Biochem Research Unit For ₹147 Cr

Aurobindo Pharma Ltd, through its wholly owned subsidiary Apitoria Pharma Pvt Ltd, has acquired the contract research services business of A1 Biochem Group for ₹147 crore, strengthening its presence across the active pharmaceutical ingredient (API) lifecycle. As part of the transaction, Apitoria now holds an 80% stake in A1 Biochem Labs (India) Pvt Ltd, while […]

CW Bureau · Oct 2, 2026
GENERAL Aurobindo Pharma To Acquire 80% Stake In A1 Biochem CRO Business

Aurobindo Pharma Ltd, through its wholly owned subsidiary Apitoria Pharma Pvt Ltd, will acquire an 80% stake in the Contract Research Services business of A1 Biochem Group. The acquisition will be completed within 90 to 120 days for cash consideration at an enterprise value of $17 million on a debt-free and cash-free basis. Building CRDMO […]

CW Bureau · Jul 24, 2026